Concepedia

Momar Toure

MT

Statistics

Publications

14

Citations

2.2K

H-Index

13

Active since

1998

Affiliations

Yale University(Current)

Centre National de la Recherche Scientifique

Aix-Marseille Université

Centrale Marseille

Arvinas (United States)

Momar Toure is an author at Yale University specializing in drug discovery, medicinal chemistry, and life sciences.

ORCID

Publications per year

1998–2023

14

Publications

14

The Advantages of Targeted Protein Degradation Over Inhibition: An RTK Case Study

George M. Burslem, Blake E. Smith, Ashton C. Lai et al. · Cell chemical biology · 2017 · 673 citations · Full text

, , +13

Modular PROTAC Design for the Degradation of Oncogenic BCR‐ABL

Ashton C. Lai, Momar Toure, Doris Hellerschmied et al. · Angewandte Chemie International Edition · 2015 · 618 citations · Full text

, , +13

Targeting the C481S Ibrutinib-Resistance Mutation in Bruton’s Tyrosine Kinase Using PROTAC-Mediated Degradation

Alexandru D. Buhimschi, Haley A. Armstrong, Momar Toure et al. · Biochemistry · 2018 · 372 citations

, , +13

Assessing Different E3 Ligases for Small Molecule Induced Protein Ubiquitination and Degradation

Philipp Ottis, Momar Toure, Philipp M. Cromm et al. · ACS Chemical Biology · 2017 · 176 citations

, , +13

Design, synthesis and biological evaluation of Proteolysis Targeting Chimeras (PROTACs) as a BTK degraders with improved pharmacokinetic properties

Saul Jaime‐Figueroa, Alexandru D. Buhimschi, Momar Toure et al. · Bioorganic & Medicinal Chemistry Letters · 2019 · 89 citations · Full text

, , +14

1–5 of 14